Cytek Biosciences (CTKB)

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Dagens Cytek Biosciences, Inc. Common Stock (CTKB) aktiekurs på after-hours är , vilket speglar en NaN % after-hours rörelse sedan marknaden stängde. Företagets marknadsvärde är 567,72 mn $, med en daglig handelsvolym på  aktier. Det tidigare stängningspriset var .

Redo att börja? Följ stegen nedan, eller läs vår guide om hur man köper Cytek Biosciences aktier på Kraken med start från 10 $.